WWW.ROBTEX.COM - patritumab.eu
Search for IP or hostnames:
patritumab.eu checked at 2025-10-14T03:47:58.636Z 115ms 198/198/198 100% R:7patritumab.eu
eu
| NS | be.dns.eu | ||||||
| NS | si.dns.eu | ||||||
| NS | w.dns.eu | ||||||
| NS | x.dns.eu | ||||||
| NS | y.dns.eu | ||||||
Up
mail.patritumab.eu |
Starts with same word
patritumab.nl |
patritumab.eu |
patritumab.at |
patritumab.fr |
patritumab.de |
patritumab.be |
patritumab.it |
patritumab.pt |
patritumab.ch |
Starts similarily
AI analysis
patritumab.eu is the parent of mail.patritumab.eu.
patritumab.eu resolves to one IP number: 194.97.156.207.
other host names including roteas.de, roadmap-study.de, prefer-vte.fr, prefer-af.eu and daiichi-sankyo.org share IP numbers with patritumab.eu.
patritumab.eu is delegated to seven name servers: ns1.markmonitor.com, ns2.markmonitor.com, ns3.markmonitor.com, ns4.markmonitor.com, ns5.markmonitor.com, ns6.markmonitor.com and ns7.markmonitor.com.
patritumab.eu at least partially shares name servers with other domains, for instance ensto.pt, vwamarok.info, projectdublin.com, ironshore.sg and stirchat.com.
Host names with two IP numbers:
ns1.markmonitor.com points to: 2620:10a:80a8::1 and 149.112.160.1.
ns2.markmonitor.com points to: 2001:67c:10b8::1 and 176.97.158.1.
ns3.markmonitor.com points to: 2620:10a:80a9::1 and 149.112.161.1.
ns4.markmonitor.com points to: 2001:67c:1bc::1 and 192.174.68.1.
ns5.markmonitor.com points to: 2620:10a:80a8::2 and 149.112.160.2.
ns6.markmonitor.com points to: 2001:67c:10b8::3 and 176.97.158.3.
ns7.markmonitor.com points to: 2620:10a:80a9::2 and 149.112.161.2.
patritumab.eu is handled by a single mail server, mail.patritumab.eu.
mail.patritumab.eu resolves to IP 194.97.156.191.